## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the supplied abstract; no full text, figures, tables, or supplementary materials were provided
- **Shared manuscript claim summary** The authors present TFBindFormer, a hybrid cross-attention transformer that integrates genomic DNA features with TF-specific representations from protein sequences and structures, and claim that it consistently outperforms DNA-only baselines across hundreds of cell-type-specific TFs and hundreds of millions of genome-wide DNA bins, with substantial gains in AUPRC and AUROC
- **Visible evidence base** Abstract text only; no quantitative results, benchmark descriptions, baseline specifications, or methodological details are available
- **Missing materials affecting confidence** Full manuscript, all figures and tables, benchmark definitions, baseline model descriptions, hyperparameter settings, statistical significance tests, and code or data availability statements

## Reviewer
- **Overall assessment** The abstract presents a plausible and potentially valuable approach to TF-DNA binding prediction by incorporating TF-specific protein information, which addresses a recognized limitation in the field. However, the evidence base is restricted to the abstract, and the claims of consistent and substantial improvement cannot be evaluated without access to the underlying data, benchmark design, and statistical analyses. The core idea is timely and could be of interest to the computational genomics community, but the current evidence is insufficient to establish the case.
- **Who would be interested in the results, and why** Computational biologists and bioinformaticians working on regulatory genomics, transcription factor binding site prediction, and deep learning applications to genomics would be the primary audience. Researchers developing sequence-based models for gene regulation may also find the cross-attention integration of protein and DNA features conceptually relevant. The potential scalability across many TFs and cell types could appeal to those interested in genome-wide regulatory annotation.
- **Major strengths** The abstract identifies a clear gap in existing computational models, namely the neglect of TF-specific protein information. The proposed architecture, a hybrid cross-attention transformer, is a reasonable and modern choice for integrating heterogeneous feature types. The scale of evaluation, described as hundreds of cell-type-specific TFs and hundreds of millions of DNA bins, suggests a comprehensive benchmarking effort if substantiated.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The claim that TFBindFormer "consistently outperforms DNA-only baselines" with "substantial gains" in AUPRC and AUROC  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract provides no quantitative results, no effect sizes, no confidence intervals, and no statistical significance testing. The terms "consistently" and "substantial" are subjective and cannot be verified.  
  - **Why it matters** Without numerical evidence and statistical support, the central performance claim is unverifiable. The reader cannot assess whether the gains are meaningful in practical terms or whether they might arise from artifacts such as data leakage or benchmark selection.  
  - **Resolution test** Provide AUPRC and AUROC values for TFBindFormer and each baseline across all evaluated TFs, along with standard deviations or confidence intervals and appropriate statistical tests (e.g., paired tests across TFs).  
  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Benchmark validity  
  - **Claim pointer** The claim of evaluation across "hundreds of cell-type-specific TFs and hundreds of millions of genome-wide DNA bins"  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract does not describe how the benchmark was constructed, how negative bins were defined, how cell-type specificity was determined, or how the DNA bins were sampled. These choices critically affect the validity of any performance comparison.  
  - **Why it matters** TF-DNA binding prediction benchmarks are highly sensitive to negative set construction and genomic context. If the benchmark is biased or unrepresentative, the reported performance gains may not generalize.  
  - **Resolution test** Describe the benchmark construction in detail, including negative set generation, genomic bin sampling strategy, TF and cell-type selection criteria, and any filtering or balancing procedures.  
  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Baseline adequacy  
  - **Claim pointer** The claim that TFBindFormer outperforms "DNA-only baselines"  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract does not specify which baselines were used, whether they are state-of-the-art, or whether they were optimized to a comparable degree. If the baselines are weak or under-tuned, the comparison is not informative.  
  - **Why it matters** The scientific contribution depends on demonstrating improvement over strong, well-established methods. Without this context, the reported gains may reflect inadequate baselines rather than genuine methodological advances.  
  - **Resolution test** List all baseline models, their sources, and their hyperparameter tuning procedures. Show that baselines are representative of current best practices in the field.  
  - **Concern ID** R1-M4  
  - **Severity** Major  
  - **Blocking** No  
  - **Axis** Methodological clarity  
  - **Claim pointer** The claim that TFBindFormer "explicitly integrates genomic DNA features with TF-specific representations derived from protein sequences and structures"  
  - **Evidence pointer** Abstract; location not provided  
  - **Concern** The abstract does not explain how protein sequences and structures are encoded, how the cross-attention mechanism operates between DNA and protein modalities, or how position-specific interactions are modeled.  
  - **Why it matters** The novelty of the approach rests on the specific architectural design. Without methodological detail, the reader cannot judge whether the approach is genuinely novel or whether the design choices are well motivated.  
  - **Resolution test** Provide a detailed description of the model architecture, including input encodings, attention mechanisms, and how protein-conditioned position-specific interactions are computed.

- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Reproducibility  
  - **Affected element** Model availability  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** No mention of code or model availability.  
  - **Required correction** State whether code, trained models, and data processing scripts will be made publicly available, and under what license.  
  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Generalizability  
  - **Affected element** Scope of evaluation  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The abstract does not indicate whether performance varies across TF families, DNA sequence contexts, or cell types.  
  - **Required correction** Report performance stratified by TF family or other relevant categories to demonstrate robustness.  
  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Comparison to prior work  
  - **Affected element** Related methods  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The abstract does not mention any prior methods that also incorporate protein information, if they exist.  
  - **Required correction** Situate the work relative to any existing approaches that use protein features for TF-DNA binding prediction.

- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The absence of quantitative results, benchmark details, and baseline specifications means the central claims cannot be assessed. R1-M4 is important for novelty assessment but is not strictly blocking if the full text provides the necessary detail.

- **Assessment against Nature-style criteria**  
  - **Originality** The idea of integrating TF-specific protein information via cross-attention is a reasonable extension of existing sequence-based models, but the abstract does not provide enough detail to establish whether the architectural contribution is genuinely novel. Assessment is currently limited.  
  - **Scientific importance** If the claims are substantiated, the work could address a real limitation in TF-DNA binding prediction and improve genome-scale regulatory annotation. The potential importance is moderate to high, but it is not yet demonstrated.  
  - **Interdisciplinary readership** The topic sits at the intersection of computational biology, genomics, and machine learning. The abstract is written in a way that is accessible to these communities, but the lack of quantitative detail limits its broader appeal.  
  - **Technical soundness** Cannot be evaluated from the abstract alone. The architectural choices are plausible, but no validation of the approach is visible.  
  - **Readability for nonspecialists** The abstract is clear and well structured, but terms such as "cross-attention transformer" and "position-specific interactions" may require some familiarity with deep learning and genomics. Overall readability is acceptable for a specialist audience.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents a promising direction, but the absence of quantitative results, benchmark details, and baseline specifications prevents any assessment of the central claims. The authors should be encouraged to provide the full manuscript and supporting data for a complete review.

## Risk / unsupported claims
- The claim of "consistent" and "substantial" performance gains is unsupported by any numerical data in the abstract.
- The claim of evaluation across "hundreds of cell-type-specific TFs and hundreds of millions of genome-wide DNA bins" is unverifiable without benchmark details.
- The claim that TFBindFormer "enables direct learning of molecular determinants underlying DNA recognition" is an interpretive statement that is not supported by the evidence presented.
- The overall conclusion that TFBindFormer is "an effective and scalable framework" is not assessable from the abstract alone.